FDA Oncology Center of Excellence Presents Conversations on Cancer: How CURE ID Can Help Find New Treatment Options for Rare Cancers November 17, 2026

https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/fda-oncology-center-excellence-presents-conversations-cancer-how-cure-id-can-help-find-new-treatment Capturing real-world treatment experiences with approved drugs used in new ways offers a promising path toward identifying additional treatment options for patients with rare cancers. This panel introduces CURE ID, a platform that serves as a free treatment registry developed by FDA and the National Center for Advancing Translational Sciences (NCATS) in collaboration with patients and clinical partners. CURE ID collects real-world reports of treatment experiences with repurposed drugs submitted by patients, caregivers, and clinicians. Panelists will discuss how CURE ID works, why every submitted case report matters, and how crowdsourced data can help accelerate development of new treatments for rare cancers. Attendees will learn how to submit their own experiences and how the broader rare cancer community can benefit when individual stories come together to advance shared knowledge.